Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib Maintenance in Advanced Endometrial Cancer
NCT03745950Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Feb 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in endometrial carcinoma, sponsored by ARCAGY. Started Feb 2019; status: completed.
02
Drugs
olaparib
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT03745950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03745950.